CUTRIGNELLI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 6.225
AS - Asia 2.543
EU - Europa 2.288
SA - Sud America 641
AF - Africa 68
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.779
Nazione #
US - Stati Uniti d'America 6.131
SG - Singapore 1.038
CN - Cina 722
IT - Italia 585
BR - Brasile 549
SE - Svezia 455
HK - Hong Kong 359
RU - Federazione Russa 308
DE - Germania 237
GB - Regno Unito 161
FI - Finlandia 157
VN - Vietnam 151
UA - Ucraina 136
FR - Francia 73
CA - Canada 51
JP - Giappone 45
ID - Indonesia 44
IN - India 44
AR - Argentina 34
CI - Costa d'Avorio 33
MX - Messico 29
BD - Bangladesh 28
AT - Austria 25
BE - Belgio 24
ES - Italia 22
PL - Polonia 21
IQ - Iraq 20
IE - Irlanda 18
NL - Olanda 18
ZA - Sudafrica 18
TR - Turchia 15
CO - Colombia 13
EC - Ecuador 12
LT - Lituania 12
PK - Pakistan 12
AU - Australia 11
CZ - Repubblica Ceca 11
VE - Venezuela 10
KR - Corea 9
PY - Paraguay 9
AZ - Azerbaigian 8
IR - Iran 8
MA - Marocco 7
UZ - Uzbekistan 7
RO - Romania 6
CH - Svizzera 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
PE - Perù 4
SA - Arabia Saudita 4
BH - Bahrain 3
CL - Cile 3
KZ - Kazakistan 3
NP - Nepal 3
BB - Barbados 2
BO - Bolivia 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
MK - Macedonia 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
MR - Mauritania 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 11.779
Città #
Ashburn 668
Fairfield 650
Singapore 527
Chandler 524
Woodbridge 437
Houston 369
Hong Kong 359
Nyköping 341
Jacksonville 328
Seattle 296
Cambridge 284
Beijing 239
Wilmington 220
Ann Arbor 209
New York 170
Bari 163
Lawrence 109
Dallas 106
Roxbury 106
Los Angeles 103
Nanjing 92
Boardman 70
Des Moines 66
Helsinki 66
Brooklyn 65
Princeton 62
Ho Chi Minh City 51
Bitonto 50
São Paulo 49
Grottaglie 44
Munich 41
Bitetto 40
Jakarta 38
Chicago 37
Santa Clara 37
Hanoi 35
Abidjan 33
Buffalo 33
Shenyang 32
London 31
Napoli 31
Inglewood 30
San Diego 25
Brussels 24
Frankfurt am Main 24
Jiaxing 23
Tianjin 23
Tokyo 23
Hebei 22
Nanchang 21
Dublin 18
Montreal 18
Vienna 18
Warsaw 18
Paris 17
Turku 17
Changsha 16
Denver 16
Moscow 16
Falkenstein 15
Guangzhou 15
San Francisco 15
Toronto 15
Columbus 14
Dong Ket 14
Nuremberg 14
Rio de Janeiro 14
Stockholm 14
The Dalles 14
Johannesburg 13
Washington 13
Amsterdam 12
Belo Horizonte 12
Milan 12
Shanghai 12
Toranomon 12
Wuhan 12
Campinas 11
Council Bluffs 11
Boston 10
Manchester 10
Poplar 10
Porto Alegre 10
Redwood City 10
Atlanta 9
Baghdad 9
Brno 9
Falls Church 9
Mexico City 9
Chennai 8
Dearborn 8
Kunming 8
Orem 8
Phoenix 8
Salt Lake City 8
Baku 7
Elk Grove Village 7
Goiânia 7
Guayaquil 7
Jinan 7
Totale 8.022
Nome #
S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery 285
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 259
Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery 214
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 194
Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates 187
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 184
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. 183
A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells 178
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 178
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 173
Delivery of proapoptotic agents in glioma cell lines by TSPO ligand–dextran nanogels 171
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 162
A histochemical approach to glycan diversity in the urothelium of pig urinary bladder 160
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml 159
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 155
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. 152
Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. 152
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders 149
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 149
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 147
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 143
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration 143
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 140
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 138
TSPO ligand-methotrexate prodrug conjugates: Design, synthesis, and biological evaluation 136
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate 136
b-Cyclodextrin in personal care formulation: role on the complexation of malodors causing molecules 126
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 125
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 122
Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration 122
B-CYCLODEXTRIN IN PERSONAL CARE FORMULATION: ROLE ON THE COMPLEXATION OF MALODORS CAUSING MOLECULES 119
Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier 116
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione 113
Comparative effect of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 112
Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 112
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 110
Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency. 106
Nanoparticelle a base di Eudragit® RS 100 contenenti ciclodestrine utili per la somministrazione transmucosale di Glutatione 105
Chitosan- And Glycolchitosan-Based Nanoparticles For Methotrexate Administration Across The Blood Brain Barrier 102
Comparative study of gels containing a minoxidil/MebCD complex with conventional formulation 102
The use of Eudragit RS100/cyclodextrin nanoparticles for the transmucosal administration of glutathione 102
beta-Cyclodextrin in personal care formulation: role on the complexation of malodours causing molecules 101
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer 101
Natural dendrimers: Synthesis and in vitro characterization of glycogen-cysteamine conjugates 101
Combined Eudragit RS100 cyclodextrin nanoparticles intended for transmucosal administration of Glutathione 99
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 99
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 98
Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice 98
β-cyclodextrin in personal care formulations: role on the complexation of malodours causing molecules 97
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 97
Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery 96
Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation 95
Design and synthesis of grafted TSPO ligand-amino functionalized silica-coated quantum dots 95
Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles 95
Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs 93
Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies 92
null 92
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 92
From oil to microparticulate by prilling technique: Production of polynucleate alginate beads loading Serenoa Repens oil as intestinal delivery systems 92
Chitosan- And Glycolchitosan-Based Nanoparticles For Methotrexate Administration Across The Blood Brain Barrier 91
New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment 91
Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery 89
COMPARATIVE STUDY OF GELS CONTAINING A MINOXIDIL/MEbCD COMPLEX WITH CONVENTIONAL FORMULATIONS 89
Griseofulvin/carrier blends: identification of factors affecting the dissolution efficiency of solid dispersions using carrier molecular descriptors and Partial Least-Squares (PLS) regression analysis 88
Translocator Protein Ligand-PLGA conjugates nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells 88
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease 87
COLD KITS BASED ON PSMA LIGANDS FOR THE PREPARATION OF RADIOPHARMACEUTICALS 86
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing Glutathione 85
Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation 85
DEVELOPMENT OF MUCOADHESIVE MICROSPHERES AS CELECOXIB DELIVERY SYSTEMS IN THE BLADDER 84
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM–FITC labeled dendrimer 83
Relationship between dissolution efficiency of Oxazepam/carrier blends and drug and carrier molecular descriptors using multivariate regression analysis 83
New nanostructured self-assemblong inulin-a-tocopherol bioconjugates for biomedical applications 82
Stability data of extemporaneous suspensions of hydroxychloroquine sulphate in oral liquid bases after tablet manipulation 81
Development of purified glycogen derivatives as siRNA nanovectors 80
Effects of different cyclodextrins on the morphology, loading and release properties of poly(DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolam. 79
Reproducibility warning: The curious case of polyethylene glycol 6000 and spheroid cell culture 79
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells 79
Solid lipid nanoparticles as a novel delivery system for the antioxidant glutathione 78
NEW BIODEGRADABLE HYDROGELS DESIGNED FOR COLONIC DRUG DELIVERY: IN VITRO RELEASE OF THE PEPTIDES GLUTATHIONE AND OXYTOCIN 78
Morphology loading and release properties of poly(D,L-lactide-co-glycolide) microparticles containing the hypnotic agent etizolam 76
Valproic acid hydrophilic cyclodextrin complexes and valproic acid-solid 75
NEW ETHANOL-FREE FORMULATIONS CONTAINING A MINOXIDIL/METHYL-b-CICLODEXTRIN COMPLEX IN ALOPECIA TREATMENT 75
Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide 75
SYNTHESIS, CHARACTERIZATION AND CELLULAR INTERNALIZATION OF TSPO TARGETED G(4)-PAMAM DENDRIMERS INTO C6 RAT GLIOMA CELLS. 73
SPRAY DRIED MICROPARTICLES OF CHITOSAN OR ITS THIOLIC DERIVATES FOR CELECOXIB INTRAVESCICAL DELIVERY 73
NEW NANOSTRUCTURED SELF-ASSEMBLING INULIN-α-TOCOPHEROL BIOCONJUGATES FOR BIOMEDICAL APPLICATION 72
Complexation of phenytoin with some hydrophilic ciclodextrins: effect on aqueous solubilità, dissolution rate, and anticonvulsant activity in mice 72
Comparative study among some potential dermal formulations intended for glutathione administration 71
Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism 71
Valproic acid-hydrophilic cyclodextrin complexes and valproic acid-solid dispersions: evaluation of their potential pharmaceutical use 70
Effectiveness of a controlled 5-fu delivery based on fzd10 antibody-conjugated liposomes in colorectal cancer in vitro models 70
Design and synthesis of grafted TSPO ligand-amino functionalized silica-coated quantum dots 70
Preparation and characterization of gels containing a minoxidil /MebCD complex for cutaneous delivery in alopecia 69
Highly selective luminescent nanostructures for mitochondrial imaging and targeting 68
SPRAY DRIED MICROPARTICLES OF CHITOSAN OR ITS THIOLIC DERIVATES FOR CELECOXIB INTRAVESCICAL DELIVERY 67
Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique 67
SYNTHESIS, CHARACTERIZATION AND CELLULAR INTERNALIZATION OF GRAFTED TSPO LIGAND-AMINO FUNCTIONALIZED SILICA-COATED QUANTUM DOTS INTO C6 RAT GLIOMA CELLS 65
Development of mucoadhesive microspheres as celecoxib delivery systems in the bladder 65
TARGETING THE MITOCHONDRIAL PROTEIN (TSPO) THROUGH G(4)-PAMAM DENDRIMERS 64
Totale 11.027
Categoria #
all - tutte 52.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021729 0 0 0 0 0 32 124 76 160 200 74 63
2021/2022960 63 90 7 19 35 85 48 35 80 123 140 235
2022/20231.474 217 193 107 124 162 190 29 160 215 21 39 17
2023/2024711 36 107 40 40 79 201 59 53 10 13 20 53
2024/20252.468 95 47 197 87 103 223 326 223 61 111 345 650
2025/20262.500 723 244 354 522 505 152 0 0 0 0 0 0
Totale 12.116